Search research articles
Contact Us
Filters
Showing results (1-10 of 166) with videos related to
Page
of 17
Sort By:
Handbook of Experimental Pharmacology
|
April 7, 2017
Plasticity of Resistance and Sensitivity to Anti-Epidermal Growth Factor Receptor Inhibitors in Metastatic Colorectal Cancer
Andrea Sartore-Bianchi, Salvatore Siena
Cancer Cell
|
August 29, 2020
Breaking Barriers in HER2+ Cancers
Salvatore Siena, Silvia Marsoni, Andrea Sartore-Bianchi
ESMO Open
|
November 16, 2016
<i>NTRK</i> gene fusions as novel targets of cancer therapy across multiple tumour types
Alessio Amatu, Andrea Sartore-Bianchi, Salvatore Siena
Cancer Treatment Reviews
|
November 20, 2016
Overcoming dynamic molecular heterogeneity in metastatic colorectal cancer: Multikinase inhibition with regorafenib and the case of rechallenge with anti-EGFR
Andrea Sartore-Bianchi, Salvatore Siena, Giuseppe Tonini, et al.
Expert Review of Anticancer Therapy
|
August 1, 2012
New frontiers in therapeutic resistance in cancer
Andrea Sartore-Bianchi, Mauro Delorenzi, Thérèse Gagnon-Kugler, et al.
Cancer Discovery
|
October 9, 2014
Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution
Sandra Misale, Federica Di Nicolantonio, Andrea Sartore-Bianchi, et al.
Journal of the National Cancer Institute
|
September 10, 2009
Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer
Salvatore Siena, Andrea Sartore-Bianchi, Federica Di Nicolantonio, et al.
Oncology Reports
|
September 18, 2004
Low doses of subcutaneous interleukin-2 plus interferon-alpha do not induce thyroid function alterations in advanced renal cell carcinoma patients
Andrea Sartore-Bianchi, Alessandra Soriani, Raffaella Mattioni, et al.
Expert Review of Anticancer Therapy
|
February 25, 2014
Regorafenib in metastatic colorectal cancer
Andrea Sartore-Bianchi, Annalisa Zeppellini, Alessio Amatu, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 26, 2002
Intrapleural interleukin-2 induces nitric oxide production in pleural effusions from malignant mesothelioma: a possible mechanism of interleukin-2-mediated cytotoxicity?
Camillo Porta, Vittoria Rizzo, Matteo Zimatore, et al.
Page
of 17
Search research articles
Search
Showing results (1-10 of 166) with videos related to
Sort By:
Page
of 17
Handbook of Experimental Pharmacology
|
April 7, 2017
Plasticity of Resistance and Sensitivity to Anti-Epidermal Growth Factor Receptor Inhibitors in Metastatic Colorectal Cancer
Andrea Sartore-Bianchi, Salvatore Siena
Cancer Cell
|
August 29, 2020
Breaking Barriers in HER2+ Cancers
Salvatore Siena, Silvia Marsoni, Andrea Sartore-Bianchi
ESMO Open
|
November 16, 2016
<i>NTRK</i> gene fusions as novel targets of cancer therapy across multiple tumour types
Alessio Amatu, Andrea Sartore-Bianchi, Salvatore Siena
Cancer Treatment Reviews
|
November 20, 2016
Overcoming dynamic molecular heterogeneity in metastatic colorectal cancer: Multikinase inhibition with regorafenib and the case of rechallenge with anti-EGFR
Andrea Sartore-Bianchi, Salvatore Siena, Giuseppe Tonini, et al.
Expert Review of Anticancer Therapy
|
August 1, 2012
New frontiers in therapeutic resistance in cancer
Andrea Sartore-Bianchi, Mauro Delorenzi, Thérèse Gagnon-Kugler, et al.
Cancer Discovery
|
October 9, 2014
Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution
Sandra Misale, Federica Di Nicolantonio, Andrea Sartore-Bianchi, et al.
Journal of the National Cancer Institute
|
September 10, 2009
Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer
Salvatore Siena, Andrea Sartore-Bianchi, Federica Di Nicolantonio, et al.
Oncology Reports
|
September 18, 2004
Low doses of subcutaneous interleukin-2 plus interferon-alpha do not induce thyroid function alterations in advanced renal cell carcinoma patients
Andrea Sartore-Bianchi, Alessandra Soriani, Raffaella Mattioni, et al.
Expert Review of Anticancer Therapy
|
February 25, 2014
Regorafenib in metastatic colorectal cancer
Andrea Sartore-Bianchi, Annalisa Zeppellini, Alessio Amatu, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 26, 2002
Intrapleural interleukin-2 induces nitric oxide production in pleural effusions from malignant mesothelioma: a possible mechanism of interleukin-2-mediated cytotoxicity?
Camillo Porta, Vittoria Rizzo, Matteo Zimatore, et al.
Page
of 17